Cargando…

Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer's disease rat induced by amyloid beta 25-35

Alzheimer's disease (AD) has become one of the major diseases endangering the health of the elderly. Clarifying the features of each AD animal model is valuable for understanding the onset and progression of diseases and developing potential treatments in the pharmaceutical industry. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Mengying, Liu, Yuanyuan, Pi, Zifeng, Yue, Kexin, Li, Shizhe, Hu, Mingxin, Liu, Zhiqiang, Song, Fengrui, Liu, Zhongying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2019
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9064735/ https://www.ncbi.nlm.nih.gov/pubmed/35515227 http://dx.doi.org/10.1039/c9ra00302a

Ejemplares similares

Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35
por: Wei, Mengying, et al.
Publicado: (2021)

Systematically Characterize the Anti-Alzheimer’s Disease Mechanism of Lignans from S. chinensis Based on In-Vivo Ingredient Analysis and Target-Network Pharmacology Strategy by UHPLC–Q-TOF-MS
por: Wei, Mengying, et al.
Publicado: (2019)

Metabolomics analysis of multidrug-resistant breast cancer cells in vitro using methyl-tert-butyl ether method
por: Zong, Li, et al.
Publicado: (2018)

Targeted metabolome profiling by dual-probe microdialysis sampling and treatment using Gardenia jasminoides for rats with type 2 diabetes
por: Wang, Lu, et al.
Publicado: (2017)

Protective effects of Dendrobium nobile Lindl. alkaloids on amyloid beta (25–35)-induced neuronal injury
por: Zhang, Wei, et al.
Publicado: (2017)

Cirsium japonicum var. Maackii Improves Cognitive Impairment under Amyloid Beta(25-35)-Induced Alzheimer's Disease Model
por: Pang, Qi Qi, et al.
Publicado: (2022)

Oxidation of Methionine-35 in Alzheimer’s amyloid-beta peptide and the aggregation of the oxidized peptide
por: Friedemann, Merlin, et al.
Publicado: (2015)

Trace determination and characterization of ginsenosides in rat plasma through magnetic dispersive solid-phase extraction based on core-shell polydopamine-coated magnetic nanoparticles
por: Zhao, Ningning, et al.
Publicado: (2020)

Antiaggregation Potential of Padina gymnospora against the Toxic Alzheimer’s Beta-Amyloid Peptide (25–35) and Cholinesterase Inhibitory Property of Its Bioactive Compounds
por: Shanmuganathan, Balakrishnan, et al.
Publicado: (2015)

Exploring the potential pharmacodynamic material basis and pharmacologic mechanism of the Fufang-Xialian-Capsule in chronic atrophic gastritis by network pharmacology approach based on the components absorbed into the blood
por: Li, Shizhe, et al.
Publicado: (2018)

Amyloid-beta peptide (25–35) triggers a reorganization of lipid membranes driven by temperature changes
por: Ivankov, Oleksandr, et al.
Publicado: (2021)

Protective effects of Populus tomentiglandulosa against cognitive impairment by regulating oxidative stress in an amyloid beta(25–35)-induced Alzheimer's disease mouse model
por: Kwon, Yu Ri, et al.
Publicado: (2022)

Effects of the fermented Zizyphus jujuba in the amyloid β(25-35)-induced Alzheimer's disease mouse model
por: Kim, Min Jeong, et al.
Publicado: (2021)

Regulation of adenosine triphosphate-sensitive potassium channels suppresses the toxic effects of amyloid-beta peptide (25–35)
por: Kong, Min, et al.
Publicado: (2013)

Optical Imaging of Beta-Amyloid Plaques in Alzheimer’s Disease
por: Luo, Ziyi, et al.
Publicado: (2021)

Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014)

Scutellaria baicalensis stem-leaf total flavonoid reduces neuronal apoptosis induced by amyloid beta-peptide (25–35)☆
por: Wang, Ruiting, et al.
Publicado: (2013)

Role of Notch-1 signaling pathway in PC12 cell apoptosis induced by amyloid beta-peptide (25–35)
por: Liang, Huimin, et al.
Publicado: (2014)

Protective effects of Lingguizhugan decoction on amyloid-beta peptide (25-35)-induced cell injury: Anti-inflammatory effects☆
por: Xi, Feifei, et al.
Publicado: (2012)

Triptolide Inhibited Cytotoxicity of Differentiated PC12 Cells Induced by Amyloid-Beta(25–35) via the Autophagy Pathway
por: Xu, Pengjuan, et al.
Publicado: (2015)

Putative multiple reaction monitoring strategy for the comparative pharmacokinetics of postoral administration Renshen–Yuanzhi compatibility through liquid chromatography–tandem mass spectrometry
por: Sun, Yufei, et al.
Publicado: (2020)

Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022)

Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores
por: Arbor, Sage C., et al.
Publicado: (2016)

Protective Effects of Cirsium japonicum var. maackii Flower on Amyloid Beta(25–35)-Treated C6 Glial Cells
por: Pang, Qi Qi, et al.
Publicado: (2023)

Carnitine palmitoyltransferase 1 (CPT1) alleviates oxidative stress and apoptosis of hippocampal neuron in response to beta-Amyloid peptide fragment Aβ(25-35)
por: Ding, Yiyun, et al.
Publicado: (2021)

The amyloid hypothesis of Alzheimer's disease at 25 years
por: Selkoe, Dennis J, et al.
Publicado: (2016)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
por: Amakiri, Nnana, et al.
Publicado: (2019)

Amyloid-beta immunotherapy: the hope for Alzheimer disease?
por: Barrera-Ocampo, Alvaro, et al.
Publicado: (2016)

Nanostructural Differentiation and Toxicity of Amyloid-β25-35 Aggregates Ensue from Distinct Secondary Conformation
por: Song, Yongxiu, et al.
Publicado: (2018)

The neurotransmitter serotonin interrupts α-synuclein amyloid maturation
por: Falsone, S. Fabio, et al.
Publicado: (2011)

Therapeutic value of the metabolomic active neurotransmitter isorhynchophylline in the treatment of spontaneously hypertensive rats by regulating neurotransmitters
por: Alharbi, Homood, et al.
Publicado: (2021)

Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease
por: Yang, Zhenqi, et al.
Publicado: (2023)

(Dys)regulation of Synaptic Activity and Neurotransmitter Release by β-Amyloid: A Look Beyond Alzheimer's Disease Pathogenesis
por: Fagiani, Francesca, et al.
Publicado: (2021)

SIRT1 Is Involved in the Neuroprotection of Pterostilbene Against Amyloid β 25–35-Induced Cognitive Deficits in Mice
por: Zhu, Lin, et al.
Publicado: (2022)

Untargeted metabolomics analysis of the hippocampus and cerebral cortex identified the neuroprotective mechanisms of Bushen Tiansui formula in an aβ(25-35)-induced rat model of Alzheimer’s disease
por: Li, Hongli, et al.
Publicado: (2022)

The amyloid beta ion channel hypothesis of Alzheimer’s disease
por: Shirwany, Najeeb A, et al.
Publicado: (2007)

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
por: Cheignon, C., et al.
Publicado: (2017)

Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
por: Maarouf, Chera L., et al.
Publicado: (2018)

Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain
por: Wildburger, Norelle C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dejchpumhtc04quin6ba8vapke